Linden Thomas Advisory Services LLC Has $685,000 Position in Transcat, Inc. (NASDAQ:TRNS)

Linden Thomas Advisory Services LLC raised its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 23.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,477 shares of the scientific and technical instruments company’s stock after buying an additional 1,219 shares during the period. Linden Thomas Advisory Services LLC owned about 0.07% of Transcat worth $685,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Essex Investment Management Co. LLC raised its holdings in shares of Transcat by 0.4% during the 3rd quarter. Essex Investment Management Co. LLC now owns 43,444 shares of the scientific and technical instruments company’s stock valued at $5,247,000 after purchasing an additional 171 shares in the last quarter. US Bancorp DE raised its holdings in Transcat by 15.6% in the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock worth $187,000 after acquiring an additional 209 shares during the period. Ellsworth Advisors LLC raised its holdings in Transcat by 4.4% in the 3rd quarter. Ellsworth Advisors LLC now owns 5,041 shares of the scientific and technical instruments company’s stock worth $609,000 after acquiring an additional 213 shares during the period. The Manufacturers Life Insurance Company raised its holdings in Transcat by 8.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,312 shares of the scientific and technical instruments company’s stock worth $396,000 after acquiring an additional 263 shares during the period. Finally, Principal Financial Group Inc. raised its holdings in Transcat by 8.8% in the 3rd quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company’s stock worth $557,000 after acquiring an additional 373 shares during the period. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Stock Performance

NASDAQ:TRNS opened at $99.50 on Monday. The firm’s 50-day moving average is $105.40 and its 200-day moving average is $115.59. Transcat, Inc. has a 52-week low of $94.29 and a 52-week high of $147.12. The company has a market cap of $915.40 million, a price-to-earnings ratio of 50.25 and a beta of 0.71.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The business had revenue of $67.83 million for the quarter, compared to analyst estimates of $70.30 million. During the same quarter last year, the firm posted $0.41 earnings per share. Transcat’s revenue was up 8.0% on a year-over-year basis. Equities analysts predict that Transcat, Inc. will post 2.44 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently commented on TRNS. HC Wainwright reiterated a “buy” rating and issued a $156.00 target price on shares of Transcat in a report on Tuesday, October 29th. Craig Hallum lifted their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Northland Securities dropped their target price on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. Finally, Oppenheimer restated an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $130.25.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.